SCHEMBL9019868

SCHEMBL9019868

CC1(c2ccc([C@H]3C[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]4CCC5=CC6(CC[C@@H]5[C@H]43)SCCS6)cc2)SCCS1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 2/20 0.36
▸ PDK2 Q15119 2/20 0.36
▸ PDK3 Q15120 2/20 0.36
▸ PDK4 Q16654 2/20 0.36
▸ ESR1 P03372 9/20 0.35
▸ ESR2 Q92731 6/20 0.35
▸ LMNA P02545 5/20 0.35
▸ HSD17B10 Q99714 4/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ TSHR P16473 2/20 0.35
▸ SLC22A1 O15245 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ SHBG P04278 2/20 0.35
▸ SERPINA6 P08185 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ G6PD P11413 2/20 0.35
▸ PKM P14618 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20048225 0.90 ESR1 (0.37) PDK1PDK2PDK3PDK4ESR1
SCHEMBL20048226 0.90 ESR1 (0.37) PDK1PDK2PDK3PDK4ESR1
SCHEMBL21143415 0.90 ESR1 (0.37) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8539498 0.88 PDK1 (0.37) PDK1PDK2PDK3PDK4ESR1
SCHEMBL22861582 0.88 PGR (0.41) PDK1PDK2PDK3PDK4ESR1
SCHEMBL9019762 0.88 PGR (0.41) PDK1PDK2PDK3PDK4ESR1
SCHEMBL23131064 0.86 PGR (0.43) PDK1PDK2PDK3PDK4ESR1
SCHEMBL20048080 0.86 PGR (0.43) PDK1PDK2PDK3PDK4ESR1
SCHEMBL20048097 0.86 PDK1 (0.34) PDK1PDK2PDK3PDK4ESR1
SCHEMBL20048083 0.86 PGR (0.43) PDK1PDK2PDK3PDK4ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0404283-B1 11-Beta-aryl-4-estrene, method for its production and its use as a medicine SCHERING AG (DE) 1996-05-08 — — EP disclosed
EP-0404283-A2 11-Beta-aryl-4-estrene, method for its production and its use as a medicine SCHERING AKTIENGESELLSCHAFT (DE) 1990-12-27 — — EP disclosed
Send feedback